Lantheus Holdings, Inc. has made a significant update regarding its beneficial ownership in a recent SEC filing. The company reported changes in the ownership stakes held by FMR LLC, a prominent investment management firm. This update is crucial as it highlights the ongoing investment interest in Lantheus, particularly in the growing field of diagnostic substances.
Founded in Bedford, Massachusetts, Lantheus Holdings, Inc. operates in the in vitro and in vivo diagnostic substances sector, classified under SIC code 2835. The company is publicly traded on the Nasdaq under the ticker LNTH. Lantheus has been active in filing various reports, including a 10-Q and multiple 8-K forms, indicating a busy period for the firm.
The recent filing, dated November 5, 2026, is a Schedule 13G/A, which reflects the beneficial ownership of shares in Lantheus Holdings. FMR LLC reported owning 111,461.42 shares, representing 0.2% of the total common stock. Abigail P. Johnson, a key figure at FMR LLC, also holds a significant stake, further emphasizing the influence of the Johnson family in the firm.
According to the filing, FMR LLC and its affiliates have beneficial ownership of these shares, which were acquired in the ordinary course of business. The filing states, "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities." This declaration is critical as it assures investors that the ownership is not aimed at exerting control over Lantheus.
This update may impact various stakeholders, including investors, analysts, and competitors within the diagnostic substances industry. The increased transparency regarding FMR LLC's holdings could influence market perceptions and investor confidence in Lantheus Holdings. Other companies in the same sector may also be watching closely, as changes in ownership stakes can indicate shifts in market dynamics.
Looking ahead, the filing does not specify any immediate next steps or actions to be taken by Lantheus or FMR LLC. However, the continued reporting of ownership changes suggests that investors should remain vigilant regarding any future updates that may arise from this significant stakeholder.